Global Wearable Injectors Market, By Type (On-Body, Off-Body (Infusion Pump Devices)), By Therapy (Immuno-Oncology, Diabetes, Cardiovascular Diseases, Parkinson's Disease, Thalassemia, Primary Immunodeficiency Disease), By Technology (Spring-based, Motor-driven), By End-Use (Hospha itals, Clinics, Homecare, Others) – Industry Trends and Forecast to 2030.
Wearable Injectors Market Analysis and Size
Strong healthcare infrastructure and a rise in the incidence of lifestyle disorders are some of the major factors increasing the market expansion. Additionally, the rising elderly population, which is more vulnerable to such illnesses, and the growing demand for minimally invasive (MI) treatment options among the patient base are boosting the market. The biopharmaceutical industry's growth has enabled more wearable injectors to be developed, pushing the overall industry growth.
Data Bridge Market Research analyses a growth rate in the wearable injectors market in the forecast period 2023-2030. The expected CAGR of the wearable injectors market tends to be around 10.1% in the mentioned forecast period. The market was valued at USD 6.60 billion in 2022 and would grow to USD 14.26 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Wearable Injectors Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (On-Body, Off-Body (Infusion Pump Devices)), By Therapy (Immuno-Oncology, Diabetes, Cardiovascular Diseases, Parkinson's Disease, Thalassemia, Primary Immunodeficiency Disease), By Technology (Spring-based, Motor-driven), By End-Use (Hospitals, Clinics, Homecare, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
B.D. (U.S), Ypsomed (Switzerland), Amgen Inc. (U.S), Subcuject Aps (Denmark), Enable Injections (U.S), Medtronic (Ireland), Insulet Corporation (U.S.), United Therapeutics Corp. (U.S), CeQur SA (Switzerland), Gerresheimer AG (Switzerland), West Pharmaceutical Services, Inc. (U.S), Sonceboz (Switzerland), Elcam Drug Delivery Devices (Israel), Recipharm AB. (U.K), Stevanato Group (Italy), Sorrel Medical (Israel), Weibel CDS AG (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
Wearable injectors are compacted drug delivery devices that are used for single-step administration of drugs to lengthier extents. They are temporarily applied to the skin to deliver large amounts of sticky medications through the body's subcutaneous tissues more quickly and safely. They are frequently available with both on-body and off-body injectors. The device is made up of a reservoir for storage of medicine and a driving system for delivering the right amount of medicines.
Wearable Injectors Market Dynamics
Drivers
- Increasing Product Launches
Latest devices such as Sonceboz wearable injector, Dual Cartridge Injector, Auto Reconstitution Injector, Amgen wearable injector, reusable auto-injector, and Subcutaneous Drug Delivery Devices are being used in mAb-based biotherapy; wearable insulin pumps, at-home drug delivery, and in infusion therapy. The initiation of some innovative injector devices such as Sorrel Medical's wearable drug delivery device platform, QuickDose wearable injector from CCBio, Ypsodose by Ypsomed, E3D's on-body injector, and SmartDose injector with Freedom60 syringe infusion are increasing the demand for wearable injectors. The new and advanced products developed will majorly impact the market growth. Thus, this factor will boost market growth.
- Increasing Demand for Advanced Injector Technology
With the introduction of developed injector technology, the patient can never come in contact with a needle, which was a great boon to the market growth. In this process, after attaching the injector and pressing the button, the needle is inserted. The patient is being kept in awareness with all the possible indications as the medicine is released into the body and the needle automatically retracts and locks out, assuring safe and suitable disposal of the device. With the wide use of wearable injectors, there would be no needle stick injuries than the intravenous injectable and parenteral administration. Thus, this factor boosts market growth.
Opportunities
- Increased Adoption of On-body Wearable injectors
Physicians and healthcare providers adopt the on-body wearable injectors because of increasing demand, as these patches are comfortable to wear on the skin. They are also water-resistant and easy to use at home. Other benefits associated with on-body wearable injectors include decreased healthcare costs (decrease in the number of hospital visits), lifecycle management (intravenous to subcutaneous), changes in dosage frequency, flexible dosing, and automatic warming of the refrigerated drug. Thus, this factor boosts market growth.
Restraints/Challenges
- Unfavorable Reimbursement Structure In Evolving Countries
Several developing countries do not provide compensation for injectors that can be worn. For instance, in India, wearable insulin pumps are not reimbursed, and no strict guidelines for their use are provided in training. Furthermore, patients having type 1 diabetes must pay for their insulin pumps. The lack of reimbursement affects the adoption of wearable injectors and is thus anticipated to affect the market's growth in the upcoming years.
This wearable injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the wearable injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2019, Enable Injections collaborated with Sanofi for the enFuse drug delivery platform. enFuse which is a self-contained drug delivery stage that can be widely used with normal nozzles or vial vessel shapes.
- In 2020, Insulet Corporation which is a global leader in tubeless insulin pump technology with its Omnipod Insulin Management System, increased its financial help program for its customers in the U.S. who were destroyed by the pandemic. Under this program, the customer may receive upto a six-month supply of products (60 Pods) free of charge.
Global Wearable Injectors Market Scope
The wearable injectors market is segmented on the basis of type, price range, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- On-body
- Off-body
Technology
- Spring-based
- Motor-driven
- Rotary Pump
- Expanding Battery
- Other
Application
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Others
End-user
- Hospitals
- Clinics
- Home Care
- Others
Wearable Injectors Market Regional Analysis/Insights
The wearable injectors market is analyzed and market size insights and trends are provided by type, price range, application and end-user as referenced above.
The major countries covered in the wearable injectors market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has witnessed positive growth in the wearable injectors market throughout the forecast period due to increased awareness associated with using ultra-large volume wearable injectors. Also, favorable government initiatives for medical devices such as wearable injectors boost the market growth.
North America dominates the market due to the increased frequency of chronic and lifestyle-related disorders and advanced healthcare infrastructure. Moreover, the easy availability of large-volume wearable injectors also contributes to the market's growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Wearable Injectors Market Share Analysis
The wearable injectors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related wearable injectors market.
Key players operating in the wearable injectors market include:
- B.D. (U.S)
- Ypsomed (Switzerland)
- Amgen Inc. (U.S)
- Subcuject Aps (Denmark)
- Enable Injections (U.S)
- Medtronic (Ireland)
- Insulet Corporation (U.S.)
- United Therapeutics Corp. (U.S)
- CeQur SA (Switzerland)
- Gerresheimer AG (Switzerland)
- West Pharmaceutical Services, Inc. (U.S)
- Sonceboz (Switzerland)
- Elcam Drug Delivery Devices (Israel)
- Recipharm AB. (U.K)
- Stevanato Group (Italy)
- Sorrel Medical (Israel)
- Weibel CDS AG (Switzerland)
SKU-